The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1024743513 10247435 13 F 20140604 20150818 20140619 20160630 EXP US-ACTELION-A-US2014-100049 ACTELION 59.00 YR A M Y 87.98000 KG 20160630 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1024743513 10247435 1 PS VELETRI EPOPROSTENOL 1 Intravenous (not otherwise specified) 114 NG/KG, PER MIN MM032M0101,MM040M0101,MM048M0101 22260 INJECTION /min
1024743513 10247435 2 SS VELETRI EPOPROSTENOL 1 Intravenous (not otherwise specified) 115 NG/KG, PER MIN 6621540201, MM066M0101 22260 INJECTION /min
1024743513 10247435 3 SS TRACLEER BOSENTAN 1 Oral U 21290 TABLET
1024743513 10247435 4 SS REVATIO SILDENAFIL CITRATE 1 Oral 20 MG, TID 0 20 MG TID
1024743513 10247435 5 C LETAIRIS AMBRISENTAN 1 UNK U 0
1024743513 10247435 6 C ADCIRCA TADALAFIL 1 U 0
1024743513 10247435 7 C ASPIRIN. ASPIRIN 1 U 0
1024743513 10247435 8 C COUMADIN WARFARIN SODIUM 1 7.5 MG, 6 DAYS/WK U 0 7.5 MG
1024743513 10247435 9 C COUMADIN WARFARIN SODIUM 1 10 MG, 1 DAY/WK U 0 10 MG
1024743513 10247435 10 C CHLORHEXIDINE CHLORHEXIDINE 1 U 0
1024743513 10247435 11 C IODINE. IODINE 1 U 0
1024743513 10247435 12 C OXYGEN. OXYGEN 1 U 0
1024743513 10247435 13 C VITAMIN E .ALPHA.-TOCOPHEROL 1 UNK U 0
1024743513 10247435 14 C IRON IRON 1 UNK U 0
1024743513 10247435 15 C MULTIVITAMIN VITAMINS 1 UNK U 0
1024743513 10247435 16 C VITAMIN D CHOLECALCIFEROL 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1024743513 10247435 1 Pulmonary arterial hypertension
1024743513 10247435 3 Pulmonary arterial hypertension
1024743513 10247435 4 Pulmonary hypertension

Outcome of event

Event ID CASEID OUTC COD
1024743513 10247435 HO
1024743513 10247435 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1024743513 10247435 Anticoagulation drug level increased
1024743513 10247435 Arthralgia
1024743513 10247435 Catheter placement
1024743513 10247435 Catheter site discharge
1024743513 10247435 Catheter site erythema
1024743513 10247435 Catheter site infection
1024743513 10247435 Central venous catheterisation
1024743513 10247435 Decreased appetite
1024743513 10247435 Device alarm issue
1024743513 10247435 Device occlusion
1024743513 10247435 Device related thrombosis
1024743513 10247435 Dyspnoea
1024743513 10247435 Haemorrhage
1024743513 10247435 Hip fracture
1024743513 10247435 Malaise
1024743513 10247435 Skin irritation
1024743513 10247435 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1024743513 10247435 1 20100127 0
1024743513 10247435 4 201001 0
1024743513 10247435 5 201101 0
1024743513 10247435 8 2015 0
1024743513 10247435 13 201101 0
1024743513 10247435 14 201101 0
1024743513 10247435 15 201001 0